Medical Clarification Requests Can Cause Unnecessary Anxiety for Women
Translated & summarized from Kikar HaShabbat by baba
Women often experience undue anxiety when medical tests, like mammograms, require further investigation, but this usually means more information is needed, not that a serious illness has been found. The BI-RADS system helps standardize reporting, and most detected changes are benign. Following medical advice for further tests or screenings is crucial.
The story in 5 lines · by baba
- Further medical tests are often requested for clarification, not necessarily due to serious illness.
- The BI-RADS system standardizes breast imaging reports and recommendations.
- Most detected changes in medical tests are not malignant.
- Self-interpretation of medical reports can lead to unnecessary anxiety.
- Regular screenings and follow-up appointments are vital for health monitoring.
Women receiving medical test results, particularly mammograms, often experience significant anxiety when notified that further investigation is required. This notification, sometimes as brief as three words, can trigger immediate fears of serious illness, even though it typically signifies only the need for more information. The process after a mammogram involves results being analyzed, compared with previous tests, and reviewed by a doctor to determine if everything is normal or if additional steps are necessary.
The BI-RADS (Breast Imaging Reporting and Data System) is a standardized professional scale used by doctors to describe imaging findings and recommend follow-up actions. It aims to create a clear language among medical professionals and is not a "disease score." For instance, BI-RADS 0 indicates that an assessment is incomplete and requires more information, such as prior tests or additional imaging, rather than an immediate diagnosis of illness.
The Israeli Association for Cancer Control emphasizes that most changes detected in tests are not malignant. A request for further examination does not automatically mean cancer. Many additional tests or complementary examinations can resolve questions, reveal benign findings, or lead to a decision to monitor changes over time. The association stresses that even when a finding requires further investigation, it should not be automatically assumed to be cancer.
When further investigation is recommended, it can range from continued surveillance to more specific tests like a biopsy. Not all women called for follow-up will reach the biopsy stage, as findings are categorized with different follow-up plans. The association advises against trying to interpret individual numbers from a report independently, as the full meaning depends on the complete result and medical context.
Even a normal test result describes the situation only at the time it was performed. In Israel, standard recommendations for women aged 50-74 with average risk are mammograms every two years. Recommendations vary for those aged 45-49, over 75, or those with increased risk factors like a family history of cancer or BRCA gene mutations.
The article concludes by urging women not to panic when asked for further clarification. It highlights that a follow-up test is not necessarily bad news, not every finding is cancer, and self-interpretation of reports should be avoided. Completing the recommended follow-up and attending scheduled future screenings are crucial for maintaining health.